DARATUMUMAB
| Source | Section 100 (CT) | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
|  | 
|  | 
| Code & Prescriber | Medicinal Product Pack (Name, form & strength and pack size) | Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 15102WMP | DARATUMUMAB daratumumab 1.8 g/15 mL injection, 15 mL vial (PI, CMI) | 1 | 1 | 15 | $7010.28 | $31.60 | $31.60 | 
| Available brands | |||||||
| Darzalex SC | 
- Legend
- MPMedical Practitioner




